CircGPRC5A enhances colorectal cancer progress by stabilizing PPP1CA and inducing YAP dephosphorylation.

"Declarations Ethics approval and consent to participateThis research protocol was reviewed and approved by the Medical Ethics Committee of the First Affiliated Hospital of Chongqing Medical University, and informed consent was obtained from all participating patients (No. 2020–358). All the animal experiments were conducted according to the protocol approved by the Animal Experimental Research Ethics Committee of Chongqing Medicine University (No. IACUC-CQMU-2022–0019). Consent for publicationAll authors have agreed to this manuscript. Competing interestsThe authors declare no conflict of interest with the present study. Competing interests The authors declare no conflict of interest with the present study."

"Funding This work was supported by the Chongqing Key Disease Research and Application Demonstration Program (Colorectal Cancer Prevention and Treatment Technology Research and Application Demonstration [No. 2019ZX003])."